Insider Buying: Stellar Diamonds PLC (STEL) Insider Purchases 347,151 Shares of Stock

Stellar Diamonds PLC (LON:STEL) insider Karl Smithson purchased 347,151 shares of the company’s stock in a transaction dated Friday, April 6th. The stock was purchased at an average price of GBX 6 ($0.08) per share, for a total transaction of £20,829.06 ($29,237.87).

Shares of LON STEL opened at GBX 6.01 ($0.08) on Monday. Stellar Diamonds PLC has a 52-week low of GBX 2 ($0.03) and a 52-week high of GBX 9.85 ($0.14).

COPYRIGHT VIOLATION WARNING: “Insider Buying: Stellar Diamonds PLC (STEL) Insider Purchases 347,151 Shares of Stock” was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3343083/insider-buying-stellar-diamonds-plc-stel-insider-purchases-347151-shares-of-stock.html.

Stellar Diamonds Company Profile

Stellar Diamonds plc is a United Kingdom-based company, which is engaged in the acquisition, exploration, development and production of diamond properties in Sierra Leone, West Africa. The Company’s projects include Kono (Sierra Leone); Tongo (Sierra Leone); and Corporate and other activities. The Company’s projects are at the trial mining and mine development stages in Sierra Leone.

Receive News & Ratings for Stellar Diamonds Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stellar Diamonds and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Meritage Homes  Trading Up 0% After Strong Earnings
Meritage Homes Trading Up 0% After Strong Earnings
Eldorado Gold Corp  Announces Quarterly Dividend of $0.50
Eldorado Gold Corp Announces Quarterly Dividend of $0.50
Sunoco LP Announces Quarterly Dividend of $0.83
Sunoco LP Announces Quarterly Dividend of $0.83
Albireo  Expected to Post Quarterly Sales of $55.33 Million
Albireo Expected to Post Quarterly Sales of $55.33 Million
GlaxoSmithKline  Issues Quarterly  Earnings Results
GlaxoSmithKline Issues Quarterly Earnings Results
Proofpoint  Updates Q2 Earnings Guidance
Proofpoint Updates Q2 Earnings Guidance


© 2006-2018 Ticker Report. Google+.